Rafferty Asset Management, LLC Exact Sciences Corp Transaction History

Rafferty Asset Management, LLC

$29.4 Billion
Q2 2025

A detailed history of Rafferty Asset Management, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 172,708 shares of EXAS stock, worth $11 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

172,708

Previous 233,197 25.94%

Holding current value

$11 Million

Previous $10.1 Million 9.09%

% of portfolio

0.03%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$40.31 - $58.08 $2.44 Million - $3.51 Million	-60,489 Reduced 25.94%	172,708 $9.18 Million
Q1 2025 May 14, 2025	BUY	$43.04 - $58.51 $889,249 - $1.21 Million	20,661 Added 9.72%	233,197 $10.1 Million
Q4 2024 Feb 14, 2025	SELL	$49.33 - $71.97 $2.26 Million - $3.3 Million	-45,821 Reduced 17.74%	212,536 $11.9 Million
Q3 2024 Nov 13, 2024	SELL	$42.43 - $70.83 $7.82 Million - $13 Million	-184,235 Reduced 41.63%	258,357 $17.6 Million
Q2 2024 Aug 13, 2024	BUY	$41.33 - $74.26 $12 Million - $21.5 Million	289,852 Added 189.77%	442,592 $18.7 Million
Q1 2024 May 13, 2024	BUY	$56.27 - $73.77 $788,961 - $1.03 Million	14,021 Added 10.11%	152,740 $10.5 Million
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $1.48 Million - $1.9 Million	25,103 Added 22.09%	138,719 $10.3 Million
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $1.25 Million - $1.88 Million	19,016 Added 20.1%	113,616 $7.75 Million
Q2 2023 Aug 11, 2023	SELL	$62.68 - $95.05 $950,354 - $1.44 Million	-15,162 Reduced 13.81%	94,600 $8.88 Million
Q1 2023 May 11, 2023	SELL	$47.19 - $70.77 $3.35 Million - $5.02 Million	-71,003 Reduced 39.28%	109,762 $7.44 Million
Q4 2022 Feb 13, 2023	BUY	$30.35 - $53.15 $312,028 - $546,435	10,281 Added 6.03%	180,765 $8.95 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $2.49 Million - $3.85 Million	77,903 Added 84.15%	170,484 $5.54 Million
Q2 2022 Aug 12, 2022	BUY	$35.61 - $76.23 $262,338 - $561,586	7,367 Added 8.65%	92,581 $3.65 Million
Q1 2022 May 13, 2022	BUY	$57.56 - $82.54 $1.08 Million - $1.54 Million	18,713 Added 28.14%	85,214 $5.96 Million
Q4 2021 Feb 10, 2022	BUY	$72.5 - $100.68 $2.64 Million - $3.67 Million	36,431 Added 121.15%	66,501 $5.18 Million
Q3 2021 Nov 10, 2021	BUY	$90.24 - $124.05 $307,267 - $422,390	3,405 Added 12.77%	30,070 $2.87 Million
Q2 2021 Aug 10, 2021	SELL	$93.66 - $139.27 $272,831 - $405,693	-2,913 Reduced 9.85%	26,665 $3.32 Million
Q1 2021 May 10, 2021	BUY	$116.57 - $155.01 $2.17 Million - $2.89 Million	18,621 Added 169.95%	29,578 $3.9 Million
Q4 2020 Feb 10, 2021	SELL	$99.61 - $142.12 $1.9 Million - $2.71 Million	-19,063 Reduced 63.5%	10,957 $1.45 Million
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $1.36 Million - $1.91 Million	18,698 Added 165.15%	30,020 $3.06 Million
Q2 2020 Aug 07, 2020	BUY	$55.75 - $92.75 $325,412 - $541,381	5,837 Added 106.42%	11,322 $984,000
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $1.51 Million - $4.15 Million	-39,739 Reduced 87.87%	5,485 $318,000
Q4 2019 Feb 10, 2020	SELL	$77.66 - $99.74 $1.22 Million - $1.57 Million	-15,759 Reduced 25.84%	45,224 $4.18 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $1.42 Million - $1.93 Million	15,723 Added 34.74%	60,983 $5.51 Million
Q2 2019 Aug 09, 2019	SELL	$89.51 - $118.04 $1.15 Million - $1.51 Million	-12,830 Reduced 22.09%	45,260 $5.34 Million
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $3.6 Million - $5.61 Million	58,090 New	58,090 $5.03 Million

Others Institutions Holding EXAS

# of Institutions

654

Shares Held

158M

Call Options Held

1.43M

Put Options Held

2.35M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Exact Sciences Corp Transaction History